Lawrence Livermore National Laboratory (LLNL) utilizes artificial intelligence (AI) in the quest for Amyotrophic Lateral Sclerosis (ALS) treatments. The team, led by Ray and his colleagues, leveraged a surrogate model of ALS progression to analyze over 20,000 Electronic Health Records (EHRs) from veterans. With seed funding from the ALS CURE Project and support from the […]
Category: AI in Neurodegenerative Disease Research
AI in ALS Treatment Search
Lawrence Livermore National Laboratory (LLNL) utilizes artificial intelligence (AI) in the quest for Amyotrophic Lateral Sclerosis (ALS) treatments. The team, led by Ray and his colleagues, leveraged a surrogate model of ALS progression to analyze over 20,000 Electronic Health Records (EHRs) from veterans. With seed funding from the ALS CURE Project and support from the […]
